Received Apr 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 92NN2 | — |
Shingrix adjuvant only administration; Shingrix adjuvant only administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number 92NN2, expiry date 30-MAR-2027) for prophylaxis. On 18-APR-2025, the patient received Shingrix. On 18-APR-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: Shingrix adjuvant only administration) and inappropriate preparation of medication (Verbatim: Shingrix adjuvant only administration). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 22-APR-2025 Licensed practical nurse wanted to know how much time she needs to wait before giving a full dose of Shingrix after the patient only received the adjuvant portion which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered.